So when we looked at Implenia (VTX:IMPN) and its trend of ROCE, we really liked what we saw. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug ...

The company will deliver major road and transport structures across key routes in Germany and Norway by 2033.

Implenia has received a contract worth over €200m ($226.9m) for the construction of a section of the Nordmainische S-Bahn below central Frankfurt, Germany. The contract was issued by DB InfraGO, part ...

Swiss construction firm Implenia has secured a series of new contracts in the building construction sector, collectively valued at approximately SFr400m ($496.8m). The projects align with Implenia's ...

The Nordmainische S-Bahn project features development of two additional tracks between Frankfurt, Maintal, and Hanau, located north of the Main. Credit: Jiaye Liu/Shutterstock. DB InfraGO, the ...

Implenia wins another complex railway infrastructure project in Switzerland with Lot 2 Tunnel Ligerz as part of the double-track expansion Ligerz-Twann 03.08.2023 / 07:00 CET/CEST SBB awards contract ...

Swiss construction company Implenia is set to build a section of the “West Link” transportation scheme in Gothenberg, Sweden, including a railway tunnel and station. Implenia said that the contract ...

Swiss-based construction and real estate service provider that develops, builds and manages homes, workplaces and infrastructure, said it reported a record consolidated profit in 2023 while expressing ...

Today we'll evaluate Implenia AG (VTX:IMPN) to determine whether it could have potential as an investment idea. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the ...

The tunnel is part of the next phase of the North Bothnia line. Credit: Scandphoto/Shutterstock.com The Swedish Transport Authority has awarded Implenia the €40m ($43.4m) contract for the construction ...

Implenia AG (VTX:IMPN), which is in the construction business, and is based in Switzerland, saw its share price hover around a small range of CHF37.30 to CHF40.60 over the last few weeks. But is this ...

Laxey said it was selling its 51 per cent share in Implenia to various investors, including Max Rössler, whose share rises from 11.1 per cent to 13.2 per cent, Rudolf Maag (10.8 per cent) and the ...